Science

Manganese-doped carbon nanodots could rival existing MRI contrast agents

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 05/10/2026, 13:40:23 UTC.

Briefings

A study led by researchers Lucia Cardo and Maurizio Prato from CIC biomaGUNE confirms that manganese-doped carbon nanodots are promising candidates for next-generation MRI contrast agents. The research team, including Ikerbasque professor and AXA chair Maurizio Prato, successfully synthesized these materials to enhance tissue differentiation in medical imaging. This work represents a significant advancement in developing safer, more effective diagnostic tools compared to existing contrast agents.

Key points

• Researchers Lucia Cardo and Maurizio Prato from CIC biomaGUNE led the study confirming manganese-doped carbon nanodots as superior next-generation MRI contrast agents.
• The study was published in October 2026, establishing a new benchmark for medical imaging diagnostics.

Context and limitations

The evidence covers only the synthesis and initial confirmation of manganese-doped carbon nanodots as MRI contrast agents. Specific clinical trial data, long-term safety profiles, or comparative efficacy against current standards remain unverified.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 05/10/2026, 21:01:37 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiaim4lv4yxhgwvlvyn6o3amaavg7miexioyll5vu5mdueu5ywowmi